Fosfomycin: mechanisms and the increasing prevalence of resistance.
Fosfomycin
Fosfomycin–Trometamol
antibiotic
resistance
urinary tract infections
Journal
Journal of medical microbiology
ISSN: 1473-5644
Titre abrégé: J Med Microbiol
Pays: England
ID NLM: 0224131
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
pubmed:
16
11
2018
medline:
23
1
2019
entrez:
16
11
2018
Statut:
ppublish
Résumé
There are challenges regarding increased global rates of microbial resistance and the emergence of new mechanisms that result in microorganisms becoming resistant to antimicrobial drugs. Fosfomycin is a broad-spectrum bactericidal antibiotic effective against Gram-negative and certain Gram-positive bacteria, such as Staphylococci, that interfere with cell wall synthesis. During the last 40 years, fosfomycin has been evaluated in a wide range of applications and fields. Although numerous studies have been done in this area, there remains limited information regarding the prevalence of resistance. Therefore, in this review, we focus on the available data concerning the mechanisms and increasing resistance regarding fosfomycin.
Identifiants
pubmed: 30431421
doi: 10.1099/jmm.0.000874
doi:
Substances chimiques
Anti-Bacterial Agents
0
Fosfomycin
2N81MY12TE
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM